Epidemiology and Etiology of Severe Childhood Encephalitis in The Netherlands
- PMID: 32097245
- PMCID: PMC7182237
- DOI: 10.1097/INF.0000000000002551
Epidemiology and Etiology of Severe Childhood Encephalitis in The Netherlands
Abstract
Background: Limited data are available on childhood encephalitis. Our study aimed to increase insight on clinical presentation, etiology, and clinical outcome of children with severe encephalitis in the Netherlands.
Methods: We identified patients through the Dutch Pediatric Intensive Care Evaluation database and included children diagnosed with encephalitis <18 years of age admitted to 1 of the 8 pediatric intensive care units (PICU) in the Netherlands between January 2003 and December 2013. We analyzed demographic characteristics, clinical symptoms, neurologic imaging, etiology, treatment and mortality.
Results: We included 121 children with a median age of 4.6 years (IQR 1.3-9.8). The most frequently described clinical features were headache (82.1%), decreased consciousness (79.8%) and seizures (69.8%). In 44.6% of the children, no causative agent was identified. Viral- and immune-mediated encephalitis were diagnosed in 33.1% and 10.7% of the patients. A herpes simplex virus infection (13.2%) was mainly seen in children <5 years of age, median age, 1.73 years (IQR 0.77-5.01), while immune-mediated encephalitis mostly affected older children, median age of 10.4 years (IQR, 3.72-14.18). An age of ≥ 5 years at initial presentation was associated with a lower mortality (OR 0.2 [CI 0.08-0.78]). The detection of a bacterial (OR 9.4 [CI 2.18-40.46]) or viral (OR 3.7 [CI 1.16-11.73]) pathogen was associated with a higher mortality.
Conclusions: In almost half of the Dutch children presenting with severe encephalitis, a causative pathogen could not be identified, underlining the need for enhancement of microbiologic diagnostics. The detection of a bacterial or viral pathogen was associated with a higher mortality.
Conflict of interest statement
The authors have no funding or conflicts of interest to disclose.
References
-
- Tunkel AR, Glaser CA, Bloch KC, et al. ; Infectious Diseases Society of America. The management of encephalitis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2008;47:303–327. - PubMed
-
- Aygün AD, Kabakuş N, Celik I, et al. Long-term neurological outcome of acute encephalitis. J Trop Pediatr. 2001;47:243–247. - PubMed
-
- Bale JF., Jr Virus and immune-mediated encephalitides: epidemiology, diagnosis, treatment, and prevention. Pediatr Neurol. 2015;53:3–12. - PubMed
-
- Khandaker G, Jung J, Britton PN, et al. Long-term outcomes of infective encephalitis in children: a systematic review and meta-analysis. Dev Med Child Neurol. 2016;58:1108–1115. - PubMed
-
- DuBray K, Anglemyer A, LaBeaud AD, et al. Epidemiology, outcomes and predictors of recovery in childhood encephalitis: a hospital-based study. Pediatr Infect Dis J. 2013;32:839–844. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
